Standout Papers

<i><scp>HCV E1E</scp>2‐<scp>MF</scp>59</i> vaccine in chronic hepatitis <scp>C</scp> patients trea... 2013 2026 2017 2021 19
  1. HCV E1E2‐MF59 vaccine in chronic hepatitis C patients treated with PEGIFNα2a and Ribavirin: a randomized controlled trial (2013)
    P. Colombatto, Maurizia Rossana Brunetto et al. Journal of Viral Hepatitis

Citation Impact

Citing Papers

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study
2011
Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?
2008
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Hepatocellular carcinoma
2018 Standout
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of Acoustic Radiation Force Impulse (ARFI) elastography—Analysis of a cohort of 1031 subjects
2013
Modelling hepatitis C therapy—predicting effects of treatment
2015
Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage
2007
Risk Assessment of Hepatitis B Virus–Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan) σ
2010
Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement
2015
Acute viral hepatitis increases liver stiffness values measured by transient elastography
2007
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Chapter 4 Biomarkers Of Liver Fibrosis
2008
Non invasive evaluation of portal hypertension using transient elastography
2011
Portal hypertensive bleeding in cirrhosis
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
2008
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
Chronic hepatitis B: Update 2009 #
2009 Standout
A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis
2010
Transient Elastography for the Noninvasive Assessment of Liver Fibrosis: A Multicentre Canadian Study
2010
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
2019
Noninvasive assessment of liver fibrosis
2010
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
2016
Shear-Wave Elastography for the Estimation of Liver Fibrosis in Chronic Liver Disease: Determining Accuracy and Ideal Site for Measurement
2014
Non-invasive evaluation of liver fibrosis using transient elastography
2008
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C
2013
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)
2010
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma
2012
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study
2012
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
2009
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C
2009
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Adefovir Dipivoxil for Wait-Listed and Post–Liver Transplantation Patients with Lamivudine-Resistant Hepatitis B
2007
Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography
2008
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
2015
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
2017
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysis
2014
HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets
2004
Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease
2016

Works of A.M. Maina being referenced

Diagnosis and monitoring of hepatitis virus infection in liver transplant patients
2003
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases
2006
Early and Accurate Prediction of Peg-IFNs/Ribavirin Therapy Outcome in the Individual Patient With Chronic Hepatitis C by Modeling the Dynamics of the Infected Cells
2008
Rankless by CCL
2026